MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

ImmunoGen Company Profile (NASDAQ:IMGN)

Consensus Ratings for ImmunoGen (NASDAQ:IMGN) (?)
Ratings Breakdown: 6 Hold Rating(s), 5 Buy Rating(s)
Consensus Rating:Hold (Score: 2.45)
Consensus Price Target: $11.65 (16.85% downside)

Current Analysts' Coverage Summary for ImmunoGen (NASDAQ:IMGN)
Show:
DateFirmActionRatingPrice TargetActions
6/8/2015Leerink SwannBoost Price TargetMarket Perform$9.00 -> $15.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/2/2015RBC CapitalReiterated RatingOutperform$10.00 -> $15.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/1/2015Cantor FitzgeraldReiterated RatingBuy$12.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/1/2015OppenheimerReiterated RatingOutperform$13.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/1/2015Morgan StanleyUpgradeUnderweight -> Equal Weight$5.00 -> $10.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/1/2015Canaccord GenuityBoost Price TargetBuy$15.00 -> $20.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/6/2015Credit SuisseInitiated CoverageNeutral$10.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/28/2015William BlairReiterated RatingOutperformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/22/2014JPMorgan Chase & Co.Reiterated RatingHold$13.00 -> $6.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/19/2014Jefferies GroupDowngradeBuy -> Hold$20.00 -> $7.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/3/2014Cowen and CompanyInitiated CoverageMarket Perform$8.50View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/31/2014GuggenheimBoost Price Target$14.00 -> $15.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/5/2013Chardan CapitalReiterated RatingBuy$21.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/5/2013Stifel NicolausDowngradeHold -> SellView Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/26/2013Roth CapitalInitiated CoverageBuy$19.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 7/4/2013 forward)